High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):171-4. doi: 10.1016/j.clml.2012.12.004. Epub 2013 Jan 10.

Authors

Jameel Muzaffar¹, Saad Usmani, Al-Ola Abdallah, Elias Anaissie, Michele Cottler-Fox, Alejandro Restrepo

Affiliation

¹ Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. [email protected]

PMID: 23313066
DOI: 10.1016/j.clml.2012.12.004

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Antiretroviral Therapy, Highly Active*
CD4 Lymphocyte Count
HIV Infections / complications*
HIV Infections / drug therapy*
HIV Infections / immunology
HIV Infections / virology
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Multiple Myeloma / complications*
Multiple Myeloma / diagnosis
Multiple Myeloma / therapy*
Transplantation, Autologous
Treatment Outcome
Viral Load